139 related articles for article (PubMed ID: 2898038)
1. Gastric somatostatin release: evidence for direct mediation by calcitonin gene-related peptide and vasoactive intestinal peptide.
Zdon MJ; Adrian TE; Modlin IM
J Surg Res; 1988 Jun; 44(6):680-6. PubMed ID: 2898038
[TBL] [Abstract][Full Text] [Related]
2. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
Gespach C; Hui Bon Hoa D; Rosselin G
Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric acid secretion by human calcitonin gene-related peptide with picomolar potency in guinea-pig parietal cell preparations.
Umeda Y; Okada T
Biochem Biophys Res Commun; 1987 Jul; 146(2):430-6. PubMed ID: 3497632
[TBL] [Abstract][Full Text] [Related]
6. Hypergastrinemia after vagotomy is not associated with decreased gastric somatostatin.
Zdon MJ; Lewis JJ; Adrian TE; Modlin IM
Surgery; 1989 Dec; 106(6):1074-80. PubMed ID: 2573954
[TBL] [Abstract][Full Text] [Related]
7. H. pylori acutely inhibits gastric secretion by activating CGRP sensory neurons coupled to stimulation of somatostatin and inhibition of histamine secretion.
Zaki M; Coudron PE; McCuen RW; Harrington L; Chu S; Schubert ML
Am J Physiol Gastrointest Liver Physiol; 2013 Apr; 304(8):G715-22. PubMed ID: 23392237
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
[TBL] [Abstract][Full Text] [Related]
9. Vagal control of the release of somatostatin, vasoactive intestinal polypeptide, gastrin-releasing peptide, and HCl from porcine non-antral stomach.
Holst JJ; Skak-Nielsen T; Orskov C; Seier-Poulsen S
Scand J Gastroenterol; 1992 Aug; 27(8):677-85. PubMed ID: 1359631
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro.
Epelbaum J; Tapia-Arancibia L; Besson J; Rotsztejn WH; Kordon C
Eur J Pharmacol; 1979 Oct; 58(4):493-5. PubMed ID: 510382
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M; Suzuki M; Kato M
Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
[TBL] [Abstract][Full Text] [Related]
12. Colocalization of calcitonin gene-related peptide and somatostatin in pancreatic islet cells and inhibition of insulin secretion by calcitonin gene-related peptide in the rat.
Fujimura M; Greeley GH; Hancock MB; Alwmark A; Santos A; Cooper CW; Reumont KJ; Ishizuka J; Thompson JC
Pancreas; 1988; 3(1):49-52. PubMed ID: 2896352
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin analogue inhibition of isolated parietal cell secretion.
Zdon MJ; Zucker KA; Adrian TE; Modlin IM
Surgery; 1987 Dec; 102(6):967-73. PubMed ID: 2891202
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide stimulates rat gastric somatostatin release in vitro.
Koop H; Eissele R; Kühlkamp V; Bothe E; Dionysius J; Arnold R
Life Sci; 1987 Feb; 40(6):541-6. PubMed ID: 2880273
[TBL] [Abstract][Full Text] [Related]
15. Effects of some gastrointestinal peptides on isolated human and rabbit gastric glands.
Leth R; Lundell L; Olbe L
Scand J Gastroenterol; 1991 Jan; 26(1):89-96. PubMed ID: 1672470
[TBL] [Abstract][Full Text] [Related]
16. Effects of the three neuropeptides, vasoactive intestinal peptide, substance P, and calcitonin gene related peptide on basal and stimulated calcitonin release in the rat.
Månsson B; Ahrén B; Nobin A
Acta Endocrinol (Copenh); 1987 Jul; 115(3):297-300. PubMed ID: 2441551
[TBL] [Abstract][Full Text] [Related]
17. Evidence for nongastrin-mediated somatostatin inhibition of parietal cell function.
Zdon MJ; Ballantyne GH; Schafer DE; Tyshkov M; Cambria RP; Modlin IM
Surgery; 1986 Dec; 100(6):954-61. PubMed ID: 2878498
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors.
Hannon JP; Langenegger D; Waser B; Hoyer D; Reubi JC
Eur J Pharmacol; 2001 Aug; 426(3):165-73. PubMed ID: 11527540
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide release from the isolated, perfused, lower esophageal sphincter region of the rabbit and the effect of vasoactive intestinal peptide on the sphincter.
Yamashita Y; Kako N; Homma K; Hirai T; Hinder RA; DeMeester TR; Toge T; Adrian TE
Surgery; 1992 Aug; 112(2):227-33; discussion 233-4. PubMed ID: 1641762
[TBL] [Abstract][Full Text] [Related]
20. The response of a non-functional VIP- and somatostatin-containing tumour to tolbutamide in vitro.
Woltering EA; O'Dorisio TM; Mekhjian HS; Ellison EC; Dyben T; Howe BA; Tuttle SE; Minton JP
Scand J Gastroenterol Suppl; 1986; 119():129-35. PubMed ID: 2876496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
